PCVX News and Press, Vaxcyte Inc.

2024-06-23 20:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-24 17:53:23 ET More on Vaxcyte Vaxcyte, Inc. (PCVX) Q4 2023 Earnings Call Transcript Vaxcyte, Inc. 2023 Q4 - Results - Earnings Call Presentation Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst Seeking Alpha’s Q...

2024-05-23 06:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-09 12:46:08 ET More on Vaxcyte Vaxcyte, Inc. (PCVX) Q4 2023 Earnings Call Transcript Vaxcyte, Inc. 2023 Q4 - Results - Earnings Call Presentation Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst Seeking Alpha’s Q...

-- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 Program -- -- VAX-24 In...

2024-04-23 18:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-07 08:00:00 ET More on Phathom Pharmaceuticals Phathom: Undervalued Biotech With Possible GERD Treatment Label Expansion Phathom Pharmaceuticals, Inc. (PHAT) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals ...

SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today that Company management will participate in a fires...

2024-03-14 19:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-12 11:15:02 ET Wedbush analyst issues BUY recommendation for PCVX on March 12, 2024 09:17AM ET. The previous analyst recommendation was Buy. PCVX was trading at $71.49 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...